E
EMA
Guest
EMA has published an
overview of its key recommendations of 2022 regarding the authorisation and safety monitoring of veterinary medicines.
In 2022, EMA recommended ten medicines for marketing authorisation. Of these, three had a new active substance. Two were vaccines, including one new biotechnological vaccine.
A selection of these recommendations can be found in the veterinary medicines highlights document published today.
Sumber : https://www.ema.europa.eu
In 2022, EMA recommended ten medicines for marketing authorisation. Of these, three had a new active substance. Two were vaccines, including one new biotechnological vaccine.
A selection of these recommendations can be found in the veterinary medicines highlights document published today.
Sumber : https://www.ema.europa.eu